IL17A and age-related macular degeneration: Even if IL-17A ko mice develop CEP-induced pathology, we do believe that IL-17 does play a significant role in AMD because IL-17 levels are elevated in AMD patients [34] and the IL-17RC promoter region is preferentially hypomethylated in AMD patients [58].